Vistagen Therapeutics (VTGN) Cash & Current Investments (2011 - 2026)
Vistagen Therapeutics (VTGN) recorded Cash & Current Investments of $31.73 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 49.8% from $63.18 million a year earlier and down 30.1% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Cash & Current Investments (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics reported Cash & Current Investments of $45.4 million, down 43.6% from FY2025.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -15.1% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Current Investments came in at $80.48 million in FY2025 (-32.5%), $119.17 million in FY2024 (+616.2%), $16.64 million in FY2023 (-75.6%) and $68.14 million in FY2022 (-33.9%).
- The fiscal Q1 2027 figure is the lowest quarterly Cash & Current Investments since fiscal Q1 2024.
- On a year-over-year basis, Cash & Current Investments has declined for seven consecutive quarters, with an average decline of 11.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 616.2% in fiscal Q4 2024, against a decline of 81.5% in fiscal Q1 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $45.4 million (Q4 2026), $61.77 million (Q3 2026) and $77.18 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Vistagen Therapeutics | 7.99 Mn | -208.09 Mn | - | 31.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.73 Mn |
| Mar 31, 2026 | 45.40 Mn |
| Dec 31, 2025 | 61.77 Mn |
| Sep 30, 2025 | 77.18 Mn |
| Jun 30, 2025 | 63.18 Mn |
| Mar 31, 2025 | 80.48 Mn |
| Dec 31, 2024 | 88.56 Mn |
| Sep 30, 2024 | 97.58 Mn |
| Jun 30, 2024 | 108.36 Mn |
| Mar 31, 2024 | 119.17 Mn |
| Dec 31, 2023 | 126.60 Mn |
| Sep 30, 2023 | 37.61 Mn |
| Jun 30, 2023 | 9.62 Mn |
| Mar 31, 2023 | 16.64 Mn |
| Dec 31, 2022 | 25.04 Mn |
| Sep 30, 2022 | 35.30 Mn |
| Jun 30, 2022 | 52.00 Mn |
| Mar 31, 2022 | 68.14 Mn |
| Dec 31, 2021 | 83.70 Mn |
| Sep 30, 2021 | 93.63 Mn |
API Access
Vistagen Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();